Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Urology,Oncology
Reference12 articles.
1. ManVsProstate; www.ManVsProstate.com; contacts at: DrWayneKuang@ManVsProstate.com; First Edition: 2023.
2. Cindolo L, Pirozzi L, Fanizza C, Romero M, Tubaro A, Autorino R, et al. Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study. Eur Urol. 2015;68:418–25.
3. Presicce F, De Nunzio C, Gacci M, Sosnowsky R, Lombardo R, Porpiglia F, et al. The influence of the medical treatment of LUTS on benign prostatic hyperplasia surgery: do we operate too late? Minerva Urol Nefrol. 2017;69:242–52.
4. Rubilotta E, Balzarro M, Trabacchin N, Righetti R, D’Amico A, Blaivas JG, et al. Post-void residual urine ratio: A novel clinical approach to the post-void residual urine in the assessment of males with lower urinary tract symptoms. Investig Clin Urol. 2021;62:470–6.
5. Ornaghi PI, Porreca A, Sandri M, Sciarra A, Falsaperla M, Ludovico GM, et al. Features of patients referring to the outpatient office due to benign prostatic hyperplasia: analysis of a national prospective cohort of 5815 cases. Prostate Cancer Prostatic Dis. 2022. https://doi.org/10.1038/s41391-022-00575-w.